AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown-Peterside, P.
Right arrow Articles by Koblin, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown-Peterside, P.
Right arrow Articles by Koblin, B. A.
Related Collections
Right arrow Insurance
Right arrow Health Promotion
Right arrow HIV/AIDS
Right arrow Immunization/Vaccines
Right arrow Smoking Cessation
September 2001, Vol 91, No. 9 | American Journal of Public Health 1377-1379
© 2001 American Public Health Association

FIELD ACTION REPORT

Retaining Hard-to-Reach Women in HIV Prevention and Vaccine Trials: Project ACHIEVE

Pamela Brown-Peterside, PhD, Evelyn Rivera, Debbie Lucy, MS, Izzie Slaughter, MPH, Leigh Ren, MS, Mary Ann Chiasson, DrPH and Beryl A. Koblin, PhD

Pamela Brown-Peterside, Evelyn Rivera, Debbie Lucy, Izzie Slaughter, Leigh Ren, and Beryl A. Koblin are with the Laboratory of Epidemiology, New York Blood Center, New York, N.Y. Mary Ann Chiasson was with the New York City Department of Health.

Correspondence: Requests for reprints should be sent to Pamela Brown-Peterside, PhD, Laboratory of Epidemiology, New York Blood Center, 1309 Fulton Avenue, Room 312, Bronx, NY 10456 (e-mail: pbrownpeterside{at}nybc.org).

Project ACHIEVE, which conducts HIV prevention research studies, maintains a women's site in the South Bronx in New York City. Owing to a focused retention effort at the South Bronx site, high retention rates were achieved in a vaccine preparedness study for women at high risk of HIV infection. Comparable retention rates have been achieved in HIV vaccine trials with similar cohorts of women at this site. These results suggest that concerns about retaining hard-to-reach populations should not cause these populations to be excluded from HIV vaccine and prevention trials.




This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
A. Messiah, H. Navaline, A. Davis-Vogel, D. Tobin-Fiore, and D. Metzger
Sociodemographic and Behavioral Characteristics Associated with Timeliness and Retention in a 6-Month Follow-up Study of High-Risk Injection Drug Users
Am. J. Epidemiol., May 15, 2003; 157(10): 930 - 939.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Public Health Association